HighGravityDataInsulet — Nov 7, 2024 release
Fiscal 2024 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001145197-24-000043
Showing in the filing
International Omnipod Revenue Growth (GAAP)
“31% - 34%”
Period
Q4 FY2024
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 19
Total Omnipod revenue growth (constant curre… for FY2024
“21% to 22%”
U.S. Omnipod revenue growth (constant curren… for FY2024
“19% to 21%”
International Omnipod revenue growth (consta… for FY2024
“25% to 27%”
Drug Delivery revenue growth (constant curre… for FY2024
“(10)% to (5)%”
Total revenue growth for FY2024
“12% to 15%”
Total Omnipod revenue growth for FY2024
“13% to 16%”
Total Omnipod revenue growth (constant curre… for Q4 FY2024
“13% to 16%”
U.S. Omnipod revenue growth for FY2024
“9% to 12%”
U.S. Omnipod revenue growth (constant curren… for Q4 FY2024
“9% to 12%”
International Omnipod revenue growth for FY2024
“30% to 33%”
International Omnipod revenue growth (consta… for Q4 FY2024
“30% to 33%”
Drug Delivery revenue growth for FY2024
“(20)% to (15)% (approximately $7 million to $8 million)”
Drug Delivery revenue growth (constant curre… for Q4 FY2024
“(20)% to (15)% (approximately $7 million to $8 million)”
Gross margin for FY2024
“approximately 69%”
Operating margin for FY2024
“approximately 14.5%”
International Omnipod Revenue Growth (GAAP) for FY2024
“26% - 28%”
Total Revenue Growth (Constant Currency) for FY2024
“20% - 21%”
International Omnipod Revenue Growth (GAAP) for Q4 FY2024
“31% - 34%”
Total Revenue Growth (Constant Currency) for Q4 FY2024
“12% - 15%”
Exhibit 99.1 · the passage around this item
… earlier in the release
Omnipod 19% - 21% —% 19% - 21% International Omnipod 26% - 28% 1% 25% - 27% Total Omnipod 21% - 22% —% 21% - 22% Drug Delivery (10)% - (5)% —% (10)% - (5)% Total 20% - 21% —% 20% - 21% Three Months Ended December 31, 2024 Revenue Growth GAAP Currency Impact Constant Currency U.S. Omnipod 9% - 12% —% 9% - 12% International Omnipod 31% - 34% 1% 30% - 33% Total Omnipod 13% - 16% —% 13% - 16% Drug Delivery (20)% - (15)% —% (20)% - (15)% Total 12% - 15% —% 12% - 15% 11
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.